Charles River diving deeper into AI drug development in partnership with Valo Health

Charles River Labs, an early-stage contract research organization, is diving deeper into artificial intelligence by inking a multi-year partnership with Valo Health.

The pact with Valo follows Charles River’s agreement signed last April with Valence Discovery that gave the CRO access to Valence's artificial intelligence platform for molecular property prediction, generative chemistry and multi-parameter optimization.